|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print November 19, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00264.2002
Submitted on July 23, 2002
Accepted on November 2, 2002
1 Division of Nephrology, Hospital Universitario, Universidad del Zulia and Instituto de Investigaciones Biomedicas, Fundacite-Zulia, Maracaibo, Zulia, Venezuela
2 Division of Nephrology and Hypertension, Department of Medicine, Physiology and Biophysics, University of California, Irvine, Irvine, California, USA
* To whom correspondence should be addressed. E-mail: bri{at}iamnet.com.
Several studies have demonstrated that treatment with antioxidants improve hypertension in spontaneously hypertensive rats (SHR). Since we have shown that renal infiltration of immune cells play a role in the development of hypertension, we did the present studies to define if the anti-hypertensive effect of antioxidants was associated with improvement of renal inflammation. Melatonin (MEL) was administered as antioxidant. During 6 weeks, MEL was added to the drinking water (10 mg per 100 ml) given to a group SHR (SHR-MEL, n=10) and compared them with a group of untreated SHR (n=10) and with WKY control rats (n=10). Hypertension became increasingly severe in the SHR group (195±SD14.3 mmHg at the end of the experiment) and improved in the SHR-MEL group (149±20.4 mmHg, p<0.001) in association with a forty to sixty percent reduction in the renal infiltration of lymphocytes, macrophages, and angiotensin II positive cells. Intracellular superoxide and renal malondialdehyde content were reduced by MEL treatment, as also was the immunohistological expression of the 65kDA DNA-binding subunit of NF-
B. We conclude that MEL treatment ameliorates hypertension in the SHR in association with a reduction in the interstitial renal inflammation. Decreased activation of NF-
B, likely resulting from a reduction in local oxidative stress, may play a role in the suppression of the renal immune infiltration and, thereby, in the anti-hypertensive effects of MEL.
This article has been cited by other articles:
![]() |
Y. Quiroz, A. Ferrebuz, F. Romero, N. D. Vaziri, and B. Rodriguez-Iturbe Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction Am J Physiol Renal Physiol, February 1, 2008; 294(2): F336 - F344. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bravo, Y. Quiroz, A. Ferrebuz, N. D. Vaziri, and B. Rodriguez-Iturbe Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension Am J Physiol Renal Physiol, August 1, 2007; 293(2): F616 - F623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Gu, N. Tian, M. Shparago, W. Tan, A. P. Bailey, and R. D. Manning Jr. Renal NF-{kappa}B activation and TNF-{alpha} upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1817 - R1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stacchiotti, F. Ricci, R. Rezzani, G. Li Volti, E. Borsani, A. Lavazza, R. Bianchi, and L. F. Rodella Tubular Stress Proteins and Nitric Oxide Synthase Expression in Rat Kidney Exposed to Mercuric Chloride and Melatonin J. Histochem. Cytochem., October 1, 2006; 54(10): 1149 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Chade, M. D. Bentley, X. Zhu, M. Rodriguez-Porcel, S. Niemeyer, B. Amores-Arriaga, C. Napoli, E. L. Ritman, A. Lerman, and L. O. Lerman Antioxidant Intervention Prevents Renal Neovascularization in Hypercholesterolemic Pigs J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1816 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |